Table of Contents
Volume 5 | Issue 6
Publication Date: May 2004- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
328 |
Epidermal Growth Factor Receptor Mutations: A New Insight Chandra P. Belani |
|
Researches in Brief | ||
331-332 |
Mutations in the Epidermal Growth Factor Receptor Tyrosine Kinase May Predict Response to Gefitinib in Non–Small-Cell Lung Cancer G. Kesava Reddy, Chandra P. Belani, Vinay K. Jain |
|
333-336 |
Cyclooxygenase-2 Inhibitors as Chemopreventive Agents in Lung Cancer Nancy Price, Chandra P. Belani, Vinay K. Jain |
|
337-339 |
Current Data and Ongoing Trials in Patients with Recurrent Non–Small-Cell Lung Cancer G. Kesava Reddy, Chandra P. Belani, Vinay K. Jain, Michael C. Perry |
|
Comprehensive Reviews | ||
340-352 |
Epidermal Growth Factor Receptor as a Target to Improve Treatment of Lung Cancer Nicolaus H. Andratschke, Klaus H. Dittmann, Kathryn A. Mason, Zhen Fan, Zhongxing Liao, Ritsuko Komaki, K. Kian Ang, Luka Milas |
|
353-359 |
Gender and Lung Cancer James Gasperino, William N. Rom |
|
Original Contribution | ||
360-365 |
Effect of the Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients with Cisplatin/Gemcitabine–Treated Stage IV Non–Small-Cell Lung Cancer Vicente Alberola, Carme Sarries, Rafael Rosell, Miquel Taron, Ramon de las Peñas, Carlos Camps, Bartomeu Massuti, Amelia Insa, Ramon Garcia-Gomez, Dolores Isla, Angel Artal, Miguel Angel Muñoz, Manuel Cobo, Isabel Bover, Jose Luis Gonzalez-Larriba, Josefa Terrasa, Daniel Almenar, Ramon Barcelo, Pilar Diz, Maria Sanchez-Ronco, Jose Javier Sanchez |
|
Translational Medicine | ||
366-370 |
Activity of the Suppressor of Cytokine Signaling–3 Promoter in Human Non–Small-Cell Lung Cancer Biao He, Liang You, Zhidong Xu, Julien Mazieres, Amie Y. Lee, David M. Jablons |
|
Historical Perspective | ||
371-376 |
The Global Smoking Epidemic: A History and Status Report Robert N. Proctor |
|